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UNIVERSITY OF RHODE ISLAND 
FACULTY SENATE 
TO: President Robert L. Carothers 
FROM: Chairperson of the Faculty Senate 
Serial Number #99-00--18 
1. The attached BILL, titled The Three Hundred and Eighty-Third Report of the Curricular 
Affairs Committee: Addition of Tracks for the Pharm.D. 
is forwarded for your consideration. 
2. The original and two copies for your use are included. 
3. This BILL was adopted by vote of the Faculty Senate on March 23, 2000. 
4. After considering this bill, will you please indicate your approval or disapproval. Return 
. the original or forward itto the Board of Governors, completing the appropriate -· 
endorsement below. 
5. In accordance with Section 10, paragraph 4 of the Senate's By-Laws, this bill will become 
effective April13, 2000 three weeks after Senate approval, unless: (1) specific dates for 
implementation are written into the bill; (2) you return it disapproved; (3) you forward it 
to the Board of Governors for their approval; or he University Faculty petitions for a 
referendum. If the bill is forwarded to the Boa d of overnors, it ill not become 
effective until approved by the Board. 
March 24, 2000 
(date) 
ENDORSEMENT 
TO: Chairperson of the Faculty Senate 
FROM: President of the University 
Returned. 
a. Approved~-
John Long 
rperson of the Facul 
b . Approved subject to final approval by Board of Governors_. 
c. Disapproved _. 
~~~~ j ftl0 
- (date) 1 
r;;:?/~ 
President 
Form revised 9 I 98 
UNIVERSITY OF RHODE ISLAND 
Kingston, Rhode Island 
FACULTY SENATE 
Faculty Senate Curricular Affairs Committee 
Three Hundred and Eighty-Third Report 
Professional Tracks for the Pharm.D. Degree 
March 7, 2000 
The Three Hundred and Sixtieth Report of the Curricular Affairs Committee, Proposal 
to Establish the 6-year Doctor of Pharmacy Degree Program as the Sole Professional 
Degree Offered by the College of Pharmacy, was approved by the Faculty Senate in the 
spring 1998. The proposal included the requirement that students elect professional 
coursework in an area or "track" based on student interest. The first of these tracks, the 
Community Practice Track, was brought forward earlier this year in the Three Hundred 
and Seventy-Ninth Report of the Curricular Affairs Committee. 
At its meeting of February 22,2000, the Curricular Affairs Committee considered a 
proposal from the College of Pharmacy for seven additional tracks for the Pharm.D 
degree. The Curricular Affairs Committee has the responsibility for the approval of 
courses and requirements for the Pharm.D. Both the Curricular Affairs Committee and 
the Graduate Council must approve those courses that may be taken for graduate credit . 
. The Curricular Affairs Committee recommends that the Faculty Senate approve the 
; following seven new tracks for the Pharm.D, along with the courses and curricular 
changes that accompany the tracks. 
A. ADD: The following new courses: 
L *BMS 520 Biomedical Sciences Journal Club (II, 2) Critical reviews of current 
research reports in the field of biomedical sciences. The students will be 
evaluated on the basis of their effectiveness in organization, interpretation, 
and oral presentation, according to criteria already established in the 
department. (Lee. 3) Pre: good standing in the basic research track of the Pharm. D. 
program. Rodgers and Chichester 
2. PHC 305 Introduction to Information Technology in Pharmacy (II. 3) 
Introduction to and use of drug information data bases in pharmacy and 
pharmaceutical sciences (Lee. 3) Staff 
3. PHP 430 Advanced Infectious Diseases and Pulmonary Pharmacotherapy (II, 
3) Advanced topics in infectious diseases and pulmonary pharmacotherapy 
through literature review, data interpretation, and case scenarios. Content 
will be delivered through the perspective of clinical pharmacists. (Lee. 3) Pre: 
413. Rana and Galetko 
*Requires approval by the Graduate Council for graduate credit. Not for graduate credit 
at this time. 
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4. *PHP 460 Palliative Care (II. 3) Principles of palliative care including control 
of pain and other symptoms, and psychological, social, and spiritual issues. 
(Lec.3) Pre: 4th or 5th year standing in Pharm.D. program or permission of 
instructor. Pawasauskas, Glen, Soja 
5. PHP 520 Advanced Gastrointestinal and Endocrine (I, 3) Provides students 
with an expanded knowledge base in the area of GI and Endocrine 
pharmacotherapy, emphasizing active learning, literature evaluation, data 
interpretation. (Lee. 3) Pre: 5th year standing in the Doctor of Pharmacy Program; 
enrollment in the Pharmacotherapy Track, or permission of instructor. Luisi 
6. PHP 560 Advanced Cardiovascular and Renal Pharmacotherapy (II, 3) 
Advanced assessment and pharmacotherapeutic management of patients 
with cardiovascular and renal disease through the application of evidence-
based medicine and critical evaluation of literature. (Lee. 3) Pre: 5th year 
standing in the Doctor of Pharmacy Program; enrollment in the Pharmacotherapy 
Track, or permission of instructor. McKindley, Barbour 
B. CHANGE: Description for PHC 594 and type of course to open-ended: 
PHC 594 Experiential Tracking Practicum (I and II, 7) Students will selectone 
area to provide hands"on experience in acquiring, interpreting, and applying, 
information to a specific practice field. This will be accomplished by · 
collaborative work with a sponsor (Practicum) Pre: sixth year standing. Staff 
Students should select one related topic area that will complete their tracking 
requirements. 
PHC 594A Community Practice Practicum 
PHC 594B Pharmacotherapy Practicum 
PHC 594C Hospital Drug Information Practicum 
PHC 594D Community Practice Drug Information Practicum 
PHC 594E Clinical Data Base Development Practicum 
PHC 594F Drug Development and Regulation Practicum 
PHC 594G Cosmetics and Personal Care Practicum 
PHC 594H Biomedical Science Research Practicum 
PHC 594I Formulation Research Practicum 
PHC 594J Pharmacoeconomics and Pharmacoepidemiology Practicum 
C. ADD: The following seven new professional tracks for the Pharm. D. 
Students now have an opportunity to focus their training on a particular area 
of professional practice. Twelve credits of coursework and a focused 
tracking rotation will allow students to complete this requirement. Listed 
below are the proposed tracking options, including a description, required 
core courses, possible electives and the required rotation. 
*Requires approval by the Graduate Council for graduate credit. Not for graduate credit 
at this time. 
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1. Pharmacotherapy Practice Track 
Description 
The Pharmacotherapy Practice track will provide students with the 
knowledge and skills necessary to deliver pharmaceutical care in both 
inpatient and ambulatory practice sites. This track is designed to expand 
students' clinical knowledge base and application of pharmacotherapy to 
diverse patient populations. Elective coursework will include advanced 
topics in cardiovascular, endocrine, gastrointestinal, infectious diseases, 
internal medicine, oncology, pain, pulmonary, and renal pharmacotherapy. 
In addition, therapeutic issues related to special populations of pediatrics and 
geriatrics will be discussed. The courses emphasize active learning, primary 
literature evaluation, data interpretation, case discussion and focused 
experiential learning. Completion of this track will allow students to pursue 
advanced post-graduate clinical and research training in a variety of clinical 
areas. Furthermore, it will allow students to pursue possible careers as 
clinical practitioners providing general or focused care in acute care and 
primary care sites, managed care organizations, academia, industry and 
government. 
Required courses 
Students must select two courses (six credits) from the following list: 
• PHP 430 Advanced Infectious Disease and Pulmonary Pharmacotherapy 
• PHP 460 Palliative Care 
• PHP 520 Gastrointestinal and Endocrine Diseases 
• PHP 560 Cardiovascular-Renal Enhancement 
Electives 
Students must select two courses (six credits) from the following list: 
• PHP 430 Advanced ID and Pulmonary Pharmacotherapy 
• PHP 440 Pharmaceutical Care of Special Populations 
• PHP 498-499 Special problems 
• PHP 519 Self-Care II 
• PHP 520 Gastrointestinal and Endocrine Diseases 
• PHP 542 Controversies in Drug Literature Evaluation 
• PHP 560 Cardiovascular-Renal Enhancement 
Other courses with approval of track advisor. 
Experiential Rotation 
PHC 594 In the 6th year, students in this track must enroll in 
Pharmacotherapy Track Practicum in an area that reflects the 
Pharmacotherapy content studied. 
2. Basic Research Track 
Description 
The basic research track in the Department of Biomedical Sciences in 
designed to provide specialized education and training to selected Pharm.D. 
students, with the following general focus areas: 
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• Specialized training in theory and practice of laboratory research 
techniques and in the evaluation and quantification of research results; 
• Understanding and critical interpretation of the scientific literature; 
• Oral and written communication of research hypotheses, methods, and 
interpretation; 
• Personal experience in carrying out basic scientific research, and; 
• Awareness of career options for which basic scientific research is an 
important component. 
The basic research track will be open to all Pharm.D. students in good 
standing. It is expected that this track will accommodate up to six students 
per year, with some flexibility depending on student interest and available 
resources. If enrollment exceeds the resources available, then a competitive 
admissions policy will be implemented 
Required courses 
• BMS 525 Experimental Techniques in Biomedical Sciences 
• BMS 520 Biomedical Sciences Journal Club 
• BMS 535 Pharmaceutical Biotechnology 
Electives 
Students must select 4 credits from the following list: 
• BMS 519 Self-Care II 
• BMS 530 Drug Metabolism 
• BMS 533 Medicinal Plants 
• BMS 544 Forensic Toxicology 
• BMS 546 Advanced Toxicology 
• BMS 550 Chemistry of Natural Products 
• BMS 572 Neural Basis of Drug Action 
• BMS 633 Biosynthesis 
• BMS 635 Pharmacognosy techniques 
• BMS 636 Pharmacognosy techniques 
• BMS 641 Biochemical Pharmacology 
• BMS 642 Biochemical Toxicology 
• BMS 644 Cardiovascular Pharmacology 
• BMS 691 Selected topics in Medicinal Science 
Experiential Rotation 
PHC 594 will be a research project to be carried out either on-site, under 
direction of one of the BMS faculty, or off-site at a private industrial or 
biotechnology firm. The project will be completed either in the summer or in 
the fall between the fifth and sixth years (eight weeks off-site), or in the fall of 
the sixth year (14 weeks on-site) . Regardless of when the project is carried 
out, the student will register for the course in the fall of the sixth year. The 
BMS department is in the process of obtaining commitments for guaranteed 
industry-supported fellowships, required for the off-site experiences. It is 
intended that the research experience will be an application of principles and 
techniques obtained in the other courses of the tracking program. Therefore, 
parts of the curriculum will be designed considering input from industry 
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representatives. Student performance will be assessed on the basis of an 
evaluation provided by his or her supervisor, along with a written and 
possible an oral report provided by the student. The report will be due early 
(off-site) or at the end (on-site) of the fall semester of the sixth year. 
3. Drug Information and Technology Track 
Description 
The drug information and Technology Track will provide basic training for 
Pharm.D. students who are interested in developing their drug information 
and/ or computer skills. It is aimed at students who would like to pursue a 
career in pharmaceutical related information services, and at students who 
want to enhance their computer knowledge. The Drug Information and 
Technology track will strengthen computer skills, expand their knowledge of 
computer and network systems and provide experience in the development 
and analysis of pharmaceutical related databases. It will give them practical 
experience in providing drug information to health professionals as well as 
the public. 
The track will consist of courses given by the College of Pharmacy ano 
Department of Management Science and Information (MSI). Students will 
take an introductory course given by this College, which will provide an 
overview of drug information services; the development of pharmaceutical 
related databases and basic computer networks located in the College. 
Students will also take a course in the MSI department, which will provide 
them with a solid basis in microcomputer software. The students will then 
select two courses from a series depending upon their individual interests. 
One of these courses is a special problems course given by a member in the 
information technology track that involves a computer-based project. This 
project could be based here at the College or at an external site such as CVS 
or a hospital-based drug information site. The information technology 
committee overseeing the track would approve all special projects. Students 
will present their projects in a seminar format. 
Required courses 
• PHC 305 Introduction to Information Technology in Pharmacy 
• MSI 310 Application of Microcomputer Software in Business 
Electives 
Students must take two courses from the following list: 
• BAC 110 Business computer applications (or equivalent) 
• COM 320 Oral Communication for Business Professions 
• COM 337 Intercultural communication 
• MSI 410 Information technology in Business Organizations 
• MSI 420 Business applications programming 
• MSI 430 Management of systems an design 
• MSI 440 Management of data bases 
• APS I BMS /PHP448 Special problems in information technology in 
pharmacy 
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• BMS 535 Pharmaceutical biotechnology 
• PHP /BMS 519 Self-Care II Self-Care II 
• PHP 501 Pharmaceutical care for special populations 
• PHP 542 Controversies in drug literature evaluation 
• LSC 504 Reference information services 
• LSC 549 Information storage retrieval 
Experiential Rotation 
The tracking clerkship will focus on the delivery of drug information and the 
use of current technology in many different settings, based on the student's 
interest. Currently under development are clerkships in the areas of hospital 
based drug information, community practice drug information, 
hospital/ community practice clinical data base development formulary and 
drug utilization management, as well as drug manufacturer based 
experiences. 
One of the following rotations: 
• PHC 594 Hospital Drug Information Clerkship 
• PHC 594 Community Practice Drug Information Center Clerkship 
• PHC 594 Hospital/Community Practice Clinical Data Base 
Development 
• PHC 594 Formulary and Drug Utilization Management 
4. Drug Development and Regulation Track 
Description 
The Regulatory Affairs track will allow students the opportunity to explore 
areas of interest in Pharmacokinetics, biopharmaceutics, and scientific aspects 
of the regulations affecting the design, production, evaluation and 
distribution of drug products. Students will have the opportunity to examine 
current literature. Problem solving skills will be nurtured. 
Required course 
• APS 670 Methods in Pharmacokinetics and Pharmacodynamics 
• APS 621 Manufacturing Pharmacy I 
Electives 
Students must select three courses (8 credits) from the following list: 
• APS 621 Manufacturing pharmacy 
• APS 670 Methods in Pharmacokinetics and Pharmacodynamics 
• APS 540 Epidemiological Methods 
• APS 550 Pharmacoepidemiology 
• APS 497 or 498 Special Projects 
• esc 201 Introduction to computer programming 
• IME 533 Advanced statistical methods for research and industry 
• 400-level statistics course in clinical trials methods 
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Experiential Rotation 
PHC 594 The research practicum will involve students carrying out a 
research project. The students will work in close collaboration with a faculty 
member as well as MS and Ph.D. graduate students. 
5. Cosmetics and Personal Care Products Technology Track 
Description 
This track is closely related to Community Practice. It will provide in-depth 
understanding of the cosmetics, self-care products and dermatologicals from 
conception, to marketing, to consumer use. Many self-care products in the 
market such as sunscreens, the majority of moisturizers, and products with 
"anti-aging" claim already have OTC status. Introduction of the cosmetic 
track is timely because with increasing utility of the "cosmeceuticals," the 
cosmetics industry is likely to be regulated within the next decade. Students 
who choose the cosmetic track will have an opportunity to study an array of 
courses that will provide an understanding of the utility and marketing of 
cosmetics, self-care products and dermatologicals. 
Required courses 
• APS 498 Special Problems 
• APS 530 Fundamentals of Cosmetic Science 
• APS 532 Cosmetic Product Formulation 
Electives 
Students must select two courses (six credits) from the following list: 
• APG405 Psychological Anthropology 
• APS453 Drug Marketing Principles 
• APS 461 Health Related Systems 
• APS531 Basic Research in Cosmetic Science 
• APS 621 Manufacturing Pharmacy I 
• APS 622 Manufacturing Pharmacy II 
• esc 201 Introduction to Computer Programing 
• IME533 Adv. Stat. Methods for Research and Industry 
• PSY 384 Cognitive Psychology 
• MGT402 Leadership and Motivation 
• BMS445 Natural Products Biotechnological Drug 
• BMS533 Medicinal Plants 
• BSL450 Consumer Law & Legislature 
• MKT311 Consumer Behavior 
• MKT331 Fundamentals of Advertising 
Experiential Rotation 
PHC 594 This track requires community Pharmacy Clerkship and/ or 
research practice activities that are carried out in the hospital-based 
dermatology clinics/practice, OTC industry, government regulatory 
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agencies, department of public health and advertising/marketing 
organizations. 
6. Formulation Track 
Description 
The formulation track will allow students the opportunity to explore areas of 
interest in formulation, manufacture, compounding of various 
pharmaceutical products and the concepts of industrial pharmacy. It is 
intended to provide a basic understanding of the physicochemical concepts 
that are essential in understanding the processes of pharmaceutical 
technology. 
Required courses 
• APS 622 Manufacturing Pharmacy II 
• APS 631 Advanced Physical Pharmacy 
Electives 
Students must pick two courses (six credits) from the following list: 
• APS 621 Manufacturing Pharmacy I 
• APS 660 Industrial Projects 
• BMS 525 Experimental Techniques in Biomedical Sciences 
• IME 533 Advanced Statistic or an Equivalent course 
Experiential Rotation 
PHC 594 Research Project to be taken in the student's sixth year. This 
research project will focus on the development, formulation, stability studies 
and manufacture of a drug product. 
7. Pharmacoeconomics and Pharmacoepidemiology Track 
Description 
The pharmacoeconomics and pharmacoepidemiology track will allow 
students the opportunity to explore areas of interest in management, 
information systems, public health and economics. Of primary importance 
will be the development of skills necessary for medical decision-making, 
formulary evaluation, organizational management, public health practice and 
the efficient delivery of appropriate healthcare. The role of pharmaceuticals 
will be emphasized. Finally, it is anticipated that students will have the 
opportunity to examine current pharmacoeconomic and 
pharmacoepidemiologic literature. 
Required course 
• APS 550 Pharmcoepidemiology or 
• APS 580 Pharmacoeconomics 
Electives 
Students must select three courses (nine credits) from the following list: 
• APS 406 Pharmacy Retailing 
• APS 440 Public Health of Infectious Disease 
• APS 453 Drug Marketing Principles 
C.A.C. #383-00-3-7 -9-
• APS540 Epidemiology 
• APS570 Case Studies in Pharmacy Law 
• APS565x Managed Care Pharmacy 
• APS580 Pharmacoeconomics 
• APS590x Quality Management 
• APS 640 Advanced Epidemiology 
• MSI664 Heath Information Systems 
• MGT303 Personnel Mgt. 
• MGT402 Leadership and Motivation 
• MSI 310 Microcomputer Applications 
• MKT301 Marketing Principles 
• MKT331 Advertising 
• INS 433 Social Insurance 
• ECN202 Macroeconomics 
• HSA360 Health Services Administration 
Experiential Rotation 
PHC 594 Community Pharmacy Clerkship to be taken in the student's sixth 
year of the program. The clerkship in the pharmacoeconomics and 
pharmacoepidemiology track will focus on the development of management 
and public health skills in community pharmacy, institutional healthcare, 
chain pharmacy, pharmacy benefit management, consultation and 
government agency environments. 
